About Us
The Mission
To aid addiction treatment facilities in breaking the cycle of addiction for their patients.
Who are we?
We are primarily a technology company, comprised of scientific researchers and business development specialists, offering a revolutionary new tool for addiction treatment by combining our new generation AI model with groundbreaking medical research.
What do we do?
Our revolutionary new tool for addiction treatment combines the technology of AI with leading medical research. Through our program clients take a 40 min. cognitive assessment along with blood samples sent to a lab and run through our Preddict.ai algorithm. With the information received our AI can accurately predict the chance of successful rehabilitation by a patient or the severity with which they are at risk of relapse. Using groundbreaking research on the use of DHEA combined with this technology patients will receive recommendations for daily dosages of DHEA and have a 3X higher abstinence rate than patients not using our DHEA program.
Why are we needed?
The addiction treatment space has been long neglected by scientific research to aid in this worldwide epidemic that has a reported 300 million people suffering from addiction across the globe as of 2021. In 1937 methadone was discovered in Germany and in the 1970’s for the first time was used to help treat heroin addiction with the thought of weening addicts off the more dangerous heroin for methadone and then eventually quitting altogether. Since this time there has been no advances in the addiction treatment space. Until Now!!!
The Science
Our proprietary algorithm was developed during the human clinical trials of our DHEA program led by Professor Gal Yadid and Rabbi Eitan Eckstein. The use of DHEA for addiction treatment has been corroborated through many studies led by the research of our own Professor Yadid as well as;
Bar-Ilan University, Israel – Gal Yadid, Rimma Maayan, Gispan-Herman Institute – Preclinical animal studies on DHEA’s effects on drug reinstatement and relapse behaviors.
Harvard Medical School – Lothar Buydens-Branchey – Research on DHEA, cortisol, and cocaine addiction.
NIDA Intramural Research Program – Steven Shoptaw – Pilot study on DHEA for cocaine dependence.
University of Cagliari, Italy – Walter Fratta, Elliot Weizman – Human trials of DHEA in opioid addicts undergoing detoxification.
Retorno and Malkishua Rehabilitation Centers, Israel – Multiple human trials of DHEA effects on relapse rates and decision-making.
Tel Aviv Sourasky Medical Center – Neuroimaging studies predicting relapse based on brain activity during DHEA treatment.
University of Georgia – Nicholas Goeders – Animal studies on DHEA’s effects on drug self-administration.
University of Mississippi – Christopher McCurdy – DHEA effects on opioid dependence behaviors.
Where Are We?
Currently we are operating in Israel, Canada and Mexico with the USA next on our expansion and hopefully soon helping people break the cycle of addiction worldwide.